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To investigate he possible direct involvement ofangiotensin II (Ang II) in ovulation and oocyte maturation, Ang II ill lOOor IOyg was administered 
at 2-h intervals in the in-vitro perfused rabbit ovaries. The addition of Ang II in the pcrfusate induced ovulation in vhro in the absence of 
gonadotropin, while ovulation did not occur in any contralaleral control ovaries. I-Iowcver, the ovulatory eflicicncy in the Ang II-trcatcd ovaries 
was signiiicantly lower than in hCG-treated ovaries. Ang II signilicantly stimulated the meiolic maturation of ovulated ova and follicular oocytes. 
Concomitant addition of lhe specific receplor antagonist of Ang II. saralasin, 30 min before the onset of Ang II administrdlion blocked Ang 
ILinduced ovulation in a complete manner. Although suralasin did not inhibit completely hCG-induced ovulation and oocytc muturalion, these 
rcsulls suggest that Ang II produced in the ovary may act locally in the process of ovulation. 
Angiotensin II; Angiotansin-receptor antagonist; Follicle rupture; Oocyte maturation; Rabbit 
1. INTRODUCTION 2. MATERIALS AND METHODS 
A funct.ional local rcnin-angiotensin system (RAS) is 
known to exist in the ovary [1,2]. Recently, Pellicier et 
al. [I] demonstrated that intraperitoneal dministration 
of Ang II receptor antagonist, saralasin, blocked ovula- 
tion in immature rats treated with pregnant mare’s 
serum gonadotropin (PMSG) and human chorionic go- 
nadotropin (hCG). This suggests that Ang II has an 
obligate role in ovulation as an intermediary of hCG 
action. In contrast, an autoradiographic study using the 
same procedure and animals [3] revealed the lack of Ang 
II receptors in preovulatory follicles containing the LH 
receptor. These results, in conjunction with data show- 
ing that Ang II receptor blockade by intraperitoncal 
injection of saralasin has no effect on ovulation [33, do 
not support the involvement of intraovarian Ang II in 
ovulation. The discrepancy of the information about 
the effects of Ang II on gonadotropin-induced ovula- 
tion in rats impeded a better understanding of the phys- 
iological role of Ang II in ovulation. No clear evidence 
of a direct role for Ang II in the process of ovulation 
has been obtained. Therefore, we investigated the direct 
effect of Ang II in the process of follicle rupture and 
oocyte maturation in the in vitro perfused rabbit ova- 
ries. This model is useful for exploring the direct effects 
of various substances on ovulation independent of any 
systemic influences [4,53. 
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1.1. MulrriaLs 
Forty-eight sexually mature female Japanese white rabbits weighing 
3.5-4.5 kg. which were cared according to Kyorin University School 
of Medicine guideline, were isolated for a minimum of 3 weeks. Ani- 
mals were caged individually and fed water and a diet of Purina rabbi1 
chow ad libitum under controlled light and tempcmture. Rabbits were 
anadietizcd with intravenous sodium pentobarbital(32 md kg), given 
heparin sulfate (I20 U/kg) for anticoagulation. and then subjected to 
laparolomy. Ovaries were excluded from further study if they ap- 
peared immature. They also were excluded if 50% or more of the 
surface tolli;l~% wcrc hemorrhagic. 
Each ovarian artery was cannulatcd in situ after ligation of the 
major nnastomoGc connections. The ovary with its artery. vein. and 
supporting adipose tissue was removed and immediately placed in a 
perfusion chamber. The perfusion fluid consisted of 150 ml of Medium 
199 (Gibco, Grand Island, NY) containing I% bovine serum albumin 
(BSA; Fraction V powder, Sigma Chemical Co., St. Louis, MO, USA), 
which was supplemented with heparin sulfate. insulin, streptomycin 
and penicillin G and adjusted to a pH of 7.4. The cannulation procc- 
dure and the perfusion technique have been described indetail [6]. The 
perfusatc was introduced through the ovarian artery cannula and was 
collected from the unligated ovarian vein and recycled. In the selected 
cxperimcnts, the ovarian vein was also cannulated using Teflon tubing 
beveled at 45O as previously described [5.7]. In a modification of this 
technique, 1% BSA was added to the basic prfusion fluid to increase 
the oncotic pressure and decrease dema formation [7]. Ovaries were 
observed every 15 min for evidence of follicle growth and rupture 
throughout the I2 h of perfusion. 
At the time of follicle rupture, the ovulated ovum surrounded by its 
cumulus mass was recovered carefully from the ovarian surface using 
a Pasteur pipltc. The time interval from hCG or Ang II administra- 
tion to follicle rupture was recorded. The ovulatory efficiency (percent 
or rollicles z- I .5 mm :hat ovulated) was calculated for each group. At 
the end of perfusion, follicular oocytes were recovered by aspiralion 
from mature follicles p I.5 mm in diameter. Both ovulated ova aad 
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follicular oocytes were assessed for stage of maturity and signs of 
degeneration. aspreviously described [S,S]. Oocytes were placed on 
slide, fixed in 2.5% glularaldchyde and then stained with 0,25% 
lacmoid in 45% ucelic acid for microscopic evaluation. The degree of 
ovum maturity was expressed as the pcrcemuge of ovu ochicving 
germinal vesicle breakdown (GVBD). Ova wcrc also assessed for de- 
generative changes including vacuolation, cylolysis. necrosis, Tri+?- 
menution and loss of spherical shape. 
In the preliminary experiment using 6 ovaries, a single injection 01 
angiorcnsin II (Ang II; Sigma Chemical Co., St. Louis, MO) a\ 100 
~6 in 0.1 ml phosphare-buffered saline (PBS) ws administered to the 
perfused rabbit ovary and the perfusau samples were withdrawn at 
I5.30.45,60.75,90, 105, 120, and 240 min aficr the onxl ol’pdusion. 
In the absence of a rabbit ovary, lhe concentrstion of Ang II in the 
perfusate wus also measured at 15, 6C. 90, 120, and 240 min after the 
administration of 1OOyg Ang II. In the first experiment. Ant: 11 at 100 
or IO py was added to the pcrfusate cvcry 2 h for 10 h of perfusion. 
The perfusatc of the contralateral ovary was treated with 0.1 1111 PBS 
alone or with 50 IU of hCG (CH-146, biological activity 3830 W/m& 
Organon. Oss, The Netherlands). In G KGtreated ovaries and 6 
ovaries perfused with medium alone, the secretion riltcs of Ang II by 
perfused rabbit ovaries were calculated by determining the dilTercnce 
in concentrnlions between the venous and at?crial samples [5]. In a 
reiatd experiment, saralasin [(Sar’.Va15,Ala”)-Ang II, Sigma Chemi- 
cal Co.] was added to the pcrfusate of one ovary while the contra- 
lateral ovary which served as a conlrol was perfused simuliancously 
wilh medium alone, Thirty minutes after the onset of perfusion, 100 
g& Ang II was administered every 2 h lo the perfusate for IO h. 
Following exposure to Anp II the ovaries were perfused for a lolaI of 
I2 h. Six ovaries from G rabbits were used in each treatment group. 
In the second experiment. one ovary was perfused with medium alone 
and served as a control. The contralaieral ovary of each rabbit was 
perfused simultaneously with saralasin at 2 x IO-“, 2 x IO-‘, or 2 x 10sb 
M in a separate chamber. Thirty minules after the onset of perfusion, 
50 IU of hCG was administered to the both ovaries. Six rabbits were 
used to assess the effect of saralasin al each dose, Ovaries were per- 
fused for a total of I? h after KG exposure. 
2.4. Ra~ioiobrlt,lunofrssu~l (RI.41 for Ang II 
The extraction of Ang II was performed as described by Beadwell 
[9] with minor modification. After the addition of [“‘l]Ang II to 
eslimale the recovery rate, the perfusate samples (0. I-O.6 ml) were 
suspended in 30 mg florisil to absorb Ang ii in the perfusate. The 
mixtures were centrifuged at 400 xg for IO min, and washed lwicc with 
1 ml distilled water. The precipitates were elutcd twice with 0.5 N 
hydrochloric-aceton solution and centrifuged at 400 xg for S min. One 
ml ofpctroleumether was added to the supcrnatant to separate unsub- 
stituted fatly acids. The aqueous extracts were evaporated under a 
stream of nitrogen gas. The extracts containing Ang II were recon- 
stituled in 500 ~1 of 0.05 M bordlc buffer (pH 8.5) containing 0.2% 
bovine serum albumin, 0.5% NaCI, and 0.1% EDTA-2Na. Aliquots 
of these xtrxts wcrc used for RIA of An13 II and derxminaiion of 
rccovcry mlcs. The avcragc recovery rate for Ang 11 was 89.5%. Ang 
II immunorcactivily in the perl’usate was examined by RIA using 
[‘z’l]Ang II purchased from New England Nuclear Co. (Boston, MA) 
and a rilbbii amisurum against an An& II-BSA conjugate [IO]. The 
antiserum crossrcact 0.3% with angiotensin I, IO-“% whh [Sar’-Ala”]- 
Ang II, 30.8% wilh nngiolensin HI, 4G.08 with dcs-[Arg’,Asp’]-Anp, 
II, and 100% with [Va15]-Ang Il. The standard curve for this assay 
ranged I’rom 0.75 to 500 pg per tube. The intra-assay and inter-assay 
coeffkicnts of variation for Ang II were 11.7% and l2.9%, respec- 
tivcly. 
All data regarding the numbers of ovulation per ovary, ovulatory 
efticiency, time ofovulation. $6 GVBD, and the concentrations of Ang 
II are represented as the mean 2 S.E.M. Statistical analysis was per- 
formed analysis of variance (ANOVA) and then Scheffii’s test was 
used to establish whether the two categories differed one frotn an- 
other. Differences were considered significantly if P was c 0.05. 
3. RESULTS AND DISCUSSION 
In order to determine the best way to introduce Ang 
II in perfused rabbit ovaries, Ang II concentration in 
the perfusate was measured uring the 2 h perfusion 
period. After a single injection of 100 ~6 Ang II in the 
presence of the perfused rabbit ovary, the concentration 
of Ang II in the perfusate was 656 f 14 ng/ml ((5.7 k 
0.1) x lo-’ M) at 1s min and decreased thereafter. At 
4 h after Ang II administration, the concentration of 
Ang II in the perfusate reduced to 68 f 10 ndml. In the 
absence of a rabbit ovary, the concentration of Ang II 
in the perfusate did not change substantially for 2 h. 
This shows that Ang II is not absorbed by the glassware 
or tubing of the perfusion system and that the apparent 
degradation of Ang II could be neglected, in the absence 
of the perfused rabbit ovary. The fact that the concen- 
tration of Ang II in the perfusate decreased as the in- 
creasing duration of ovarian perfusion suggests that 
Ang II could be metabolized in the perfused rabbit ova- 
ries. In the subsequent experiment, herefore, Ang 11 
was added to the perfusate very 2 h. 
The addition of 100 pug of Ang II at 2-h intervals to 
the perfusate induced follicle rupture in all perfused 
ovaries in the absence of gonadotropin in vitro while 
Table I 
Ovulation in ovaries perfused with medium alone, Ang II, Ant: II plus saralasin, or hCG 
100 /U 
Ang II (per ? h) Control hCG 
(medium alone) (50 IU) 
1OPg 100 yg + saralasin 
(2 x IO-h M) 
No. of ovaries perfused 
No. of ovaries ovulating 
No. of ovulations ovary per 
Ovulatory cficiency (S)’ 
Time of ovulation (h) 
I2 6 B I?. 6 
12 3 0 0 6 
3 _. 83 + 0 .__ 3Wh 1.00 t- 0.51”,’ 0 5.50 f 0.43”” 
39.4 2 4.7J ‘3.3 zt 8.3’ 
(-9 
83.0 4 4.I”C 
8.31 1 0.78 8.X f 0.68 (-) 8.57 2 0.5B 
‘The percentage of mature follicles that proceeded to rupture. 
Values with the same superscripts differ significantly: “J P < 0.01: b P 4 0.05; w P c 0.001. Values arc mean k S.E.M. 
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HOURS OF PERFUSION 
Fig, 1. Changes in angiotensin II (An9 II) production by perfused 
rabbit ovaries. Rabbit ovaries were perfused with medium alone (O- 
--o) or 50 IU hCG (u). Ovarian secretion rates (pg/min/ovary) 
were calculated by determining the diffcrcnce in concentrations bc- 
twccn venous and arterial s;imples. Data regarding hCG-treated ova- 
ries rcpresen t the mean ? S.E.M. of 6 pcrfuscd rabbit ovaries. 
In the present study, pharmacological dosages of Ang 
II were added to the perfusate when compared the con- 
centrations of Ang II secreted by the perfused rabbit 
ovaries in response to gonadotropin exposure (Fig. I). 
However, exogenous Ang II did not increase the degen- 
eration rate of either ovulated ova (Ang II at 100 pg, 
9.72 f 6.2%; IO ,ug, 11.1 & 6.4%) as compared to the 
hCG-treated control (9.4 1: 3.8%) or follicular oocytes 
(Ang II at lOOpg, 12.5 f 5.6%; lOpcg, 12.2 f 5.3%) as 
compared to the untreated control (5.7 1 3.9%). 
ovulation did not occur in any contralateral ovary per- To assess the role of endogenous Ang II in the pre- 
fused with medium alone (Table I). Saralasin added to ovulatory process, the effect of saralasin on hCG-in- 
the perfusate 30 min before the onset of Ang II admin- duced ovulation in vitro was determined (Table II). Sar- 
istration completely blocked Ang II-induced ovulation. alasin alone neither induced follicle rupture nor stimu- 
However, both the ovulatory efficiency, percent of folli- lated the meiotic maturation of follicular ooeytes. All 
cles 2 I .5 mm which ovulated, and the number of ovula- ovaries treated with hCG alone or with hCG plus sara- 
tions per ovary in the Ang II-treated ovaries were signif- lasin at 2 x lo-’ or 2 x IO-’ M ovulated. Three of six 
icantly lower than in hCG-treated ovaries (P < 0.01). ovaries treated with hCG plus saralasin at 2 x lo-” M 
This implies that other components within the preovula- failed to ovulate. The mean number of ovulations per 
tory follicular environment may also be required for ovary was significantly reduced in ovaries perfused with 
follicles to rupture. Daud et al. [I l] recently demon- saralasin, as compared to hCG-treated controls. The 
strate that the follicular Ang II receptor is suppressed addition of saralasin to the perfusatc blocked hCG- 
in healthy follicles as they are sensitized to circulating induced ovulation in a dose-dependent manner (Table 
gonadotropin, The fact that ovulatory efficiency in Ang II). The secretion rate of Ang II by the perfused rabbit 
11-treated ovaries is low, regardless of the administra- ovaries was not detectable in the absence of gona- 
tion of pharmacological dosage of Ang II, as compared dotropin. The addition of hCG to the perfusate signifi- 
to the hCG-treated control, may also be due to the cantly increased Ang II production throughout he en- 
suppression of Ang 11 receptor during the preovulatory tire perfusion periods (Fig. I). The secretion rate of Ang 
maturational process. In the in vivo studies described by 
Pellicer et al. [I] and Daud et al. [2], the possibility 
cannot be completely excluded that the Ang II receptor 
antagonist has non-specific effects in the process of ovu- 
lation with the systemic influence or that the existence 
of the renal RAS affects a physiological action of Ang 
1 I in gonadotropin-induced ovulation. However, the 
present data showing that Ang II stimulates directly 
follicle rupture in the absence of any systemic inlluenw 
suggests the possible involvement of Pang II in the proc- 
ess of ovulation. 
Table II 
Effects of saralasin on hCCi~induced ovulation and oocytc maturation in the in vitro perfused rabbit ovaries 
Saralasin + hCG (50 IU) hCG Saralaain 
(50 IU) (2 x IO-” M) 
2x IO+M 2 x lo-’ M 2 x lo-b M 
No. of ovaries perfused 
No. of ovaries ovulating 
No. of ovulations per ovary 
Ovulatory efticicncy (%)’ 
Time of ovulation (h) 
6 6 6 I8 6 
3 6 6 18 0 
1.00 ? 0,512 2.75 f 0.42h 2.83 IL 0.75’ 4 89 c_ 0 4+* 0 
I59 f 8.9”,‘.’ 43.2 f 6.3ca’ 53.8 2 4.3’ 79.1 + 119L 0 
8.97 + I,20 8.53 & 0.26 7.G6 2 0.28 8.51 + 0.23 (-) 
5% GVBD’ 
GWlated ova 38.9 dz 14.2” 78.1 ztz 9.3 65.5 2 Il.5 86.6 f 6.0” 
Fullicular aocylcs 77.8 ? 10.2 89.3 z!I 5.8 83.3 f 16.6 94.4 I- 6.7 
‘The perccntagc of mature follicles that proceeded IO rupture. 
‘The percentage of oacytes that achieved germinal vesicle breakdown (GVBD). 
Values with the same superscripts differ significantly: “J P c 0.01: b*-~s@ p e 0.05; d P c 0.001. Values arc mean + S.E.M. 
(-) 
5.2 f 3.3 
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J!iiL 
Ana II IlOre 
Fig. 2. Oocytc maturation in ovaries perfused with medium alone, Ang 
II. Ang II plus salarasin, or hCG. The degrLz of oocyte maturation 
in ovulated ova and follicular oocytes was expressed as the percemage 
or oocytcs achieving germinal vesicle breakdown (GVBD). a, P < 
0.001; b, P c 0.01; c, P c 0.05. 
II by the perfused rabbit ovaries reached its maximum 
6 II after exposure to hCG and then declined. This im- 
plies that a small amount of Ang II can be synthesized 
by rabbit ovaries in response to gonadotropin. These 
data, taken together with other data showing that the 
increase in plasma prorenin concentration occurred al- 
most exactly at the time of ovulation [12,13] and that 
gonadotropin stimulates renin activity and Ang il im- 
munoreactivity in follicular fluid [14], support the exis- 
tence in the ovary of an intrinsic RAS, which is respon- 
sible as a possible intermediary of gonadotropin-in- 
duced ovulation. Husain et al. [lS] could not find the 
expected autoradiographic distribution of Ang II recep- 
tors in every developing follicle, suggesting that not all 
preovulatory follicles respond necessarily to exogenous 
or endogenous Ang II. Alternatively, the failure of Ang 
II to induce ovulation with an efficiency comparable to 
that of hCG implies that the response to Ang II of 
preovulatory follicles leading to ovulation can be attri- 
buted to the functional heterogeneity of follicles within 
the ovary. 
Recent data derived from human in-vitro fertilization 
program demonstrate that the prorenin concentration 
in the Wlicular fluid correlates with follicular develop 
ment, oocyte-cumulus-complex maturity, and oocyte vi- 
ability resulting in the successful pregnancy [l&17]. In 
the present study9 Ang 11 stimulated significantly the 
meiotic maturation of ovulated ova and follicular 
oocytes in the absence of gonadotropin stimulus (Fig. 
2). Furthermore, concomitant addition of saralasin at 
2 x 10-O M inhibited significantly hCG-induced oocyte 
maturation (Table II). In oocytes from Xenopus Irrevis, 
Ang 11 has been also shown to promote progesterone- 
induced oocyte maturation by mobilizing Ca” via a 
signai transferred through the gap junctions between 
the follicular cells and the oocyte [18]. These observa- 
tions, in conjunction with data showing the immunolo- 
calization of angiotensin converting enzyme in the rab- 
bit tiolemma [19], suggests that the ovar.ian RAS may 
be involved in the mechanism of mammalian oocyte 
maturation as well. Further experiments are necessary, 
however, to verify this hypothesis ince concomitant 
addition of saralasin did not inhibit completely hCCi- 
stimulated oocyte maturation (Table Il), and because 
the active renin content within the ovary was recently 
shown not to correlate with oocyte maturity [l 11. 
In conclusion, these results indicate that Ang II has 
a direct role in follicle rupture and oocyte maturation 
and support he hypothesis that Ang II produced in the 
ovary may act locally in the process of ovulation. How- 
ever, the physiological role of ovarian RAS may vary 
greatly as the ovarian follicle develops, 
REFERENCES 
[I] Pcliicier. A., Palumbo, A., DcCherney, A.H. and Naftolin, F. 
(1988) Science 240, 1660-1661. 
[2] Bumpus, F.M., Pucell, A.G.. Daud, A.I. and Husain. A. (1988) 
Am. J. Med. Sci. 295, 4OG-408. 
[33 Daud. A.[., Bumpus, F.M. and H&n, A. (1989) Science 245, 
570-87 I.
[4] Yoshimura, Y., Espcy, L., Hosoi, Y., Atlas, S.J., Ghodgaonkar, 









Yoshimura, Y., Nakamura, Y., Shiraki, M., Hirota, Y., Yamada, 
H., Ando, M,, Ubukata, Y s and Suzuki, M.( 1991) Endocrinology 
129. 193-199. 
Kobnyashi, Y., Wright, K.H., Santulli, R. and Wallach, E.E. 
(1981) Biol. Reprod. 24, 483-490. 
Dharmarajan, A.M., Yoshimura, Y., Sueoka, K., Atlas, S.J., 
Dubin, N.H., Ewing, L.L. and Wallach, E.E. (l9S8) Biol. Rc- 
prod. 38, 1137-l 143. 
Yoshimura. Y., Nakamura, Y., Oda,T., Yamada, H., Nann0.T.. 
Ando, M., Ubukata. Y. and Suzuki. M. (1990) Biol. Reprod. 43. 
1012-1018. 
Beardwell. C.G. (1971) J. Clin. Endocrinol. Mctab. 33, 2%2GO. 
Morimoto. T., Aoyama, M., Gotoh, E. and Shionoiri, H. (1983) 
Folia Endocrinol. Jpn. 59, 215-229. 
Daud. A.I., Bumpus, M. and Husain, A. (1958) Endocrinology 
177 ‘727-2734. __. _ 
Glorioso. N.. Atlas, S.A., Laragh, J.H., Jewelwin, R. and 
Sealcy. J.E. (1986) Science 233. 1422-1424. 
Scalcy, J.E., Cholst, I., Glorioso, N., Troffa, C., Wcintravb, I.D., 
James, G, and Laragh, J.H, (1987) J. Clin. Endocrinol. Metnb. 
63, l-5. 
Lightman, A., Tarlatzis, B,C., Rzosa, P.J., Culler, M.D,, Caridc, 
V.J., Negro-Vilar, A.F,, Lcnnard, D., DeChcrney, A,H. and Nai’- 
tolin, F. (1987) Am. 1. Obstet. Gynecol. 156, 808-81G. 
Husain, A.. Bumpus, F.M., DcSilva, P. and Speth, RX, (1987) 
Proc, Natl. Acad. Sci. USA 84,2489-2493. 
Cornwullis, CM., Skinner, S.L., Nayudu, P.L., Lopata, A., 
Thatcher, R.L., Yeung, S.P. and Whitworth, J.A. (1990) Hum. 
Rcprod. $413417. 
Itskovitz, J., Rubaltu, S., Rosenwoks, Z., Liu, H.C. and Scaley, 
J.E. (1991) J. Clin. Endocrinol. Mctab. 72, 165-171. 
[I81 Sandberg. K.. Bar. M., Ji, H., Markwick, A., Millnn, M. and 
Cut, K.J. (1990) Science 249, 298-301. 
[Is)] Brentjens. J R., Matsuo, S., Andres, GA., Caldwell, P.R.B. and 
Zamboni, L. (1986) Expcrientia 42, 399-402. 
[30] Howard, R.B.. Puccll. A.G. Bumpus, M. and Husain, A. (1988) 
Endocrinology 123. 2331-2340. 
308 
